Navigation Links
Clients of BMC's violence interventional advocacy program find experience supportive
Date:7/22/2014

entified the major challenges to physical and emotional healing were fear and safety, isolation as a coping mechanism, lack of trust, bitterness and symptoms of PTSD (intense fear, hypervigilance, estrangement from others, emotional detachment). Fears of going out of the house or being seen on the bus were limiting factors to moving forward. Participants felt unsociable and withdrawn, isolating themselves from friends and family. They described feeling unsafe anywhere in Boston.

Half of participants expressed feelings of distrust or apathy towards their violence intervention advocate (VIA) at first contact. As the relationship progressed, these participants described how their attitude towards their VIA changed. Many described feeling comfortable with their VIA after seeing how they genuinely cared. The other half trusted their VIA immediately. Eight described longer-term relationships that went beyond physical recovery. Almost all participants described comfort talking to their VIA while characterizing how the relationships evolved over time. Six mentioned aspects of "listening" or "understanding" in concurrence to describing the relationship progression.

Participants recounted a number of ways VIAs supported them post-injury including counseling and support, help with education, employment, and life skills. "Counseling and support was the most commonly cited service in our study," explained lead author Thea James, MD, founder and director of BMC's VIAP and an emergency room physician at BMC. "According to most participants, VIAs played a crucial role and filled a gap that is often missing from other service providers; connection to a caring and understanding adult that went beyond the scope of physical recovery from injury," added James an associate professor of emergency medicine at BUSM.

Half of participants expressed feelings of retaliation initially, but almost all chose not to retaliate since participating in VIAP for a variety of reas
'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. iFitDress.com: 2014 Glitter Evening Dresses For Worldwide Clients
2. Software Engineering Firm, Basecast, Opens Outsourced Software Design and Development Center to Better Provide Continuous Innovative Digital Solutions for their Clients
3. Inventors and InventHelp Clients Develop CPAP Accessory (DLL-2671)
4. AngelWeddingDress Will Continuously Unveil More Summer Wedding Dresses for Loyal Clients
5. Former Narconon Arrowhead Clients Participate in Sponsor a Student Holiday Program
6. Fitness Marketing Guru Reveals How to Get More Personal Training Clients Without Advertising
7. Orriant—a Frontrunner in Corporate Wellness Programs—Boasts Lower Premium Increases for Clients
8. Anti-Infection Device Invented by InventHelp Clients (KSC-736)
9. Diet Doc Hormone Diets & Weight Loss Plans Now Offers New and Old Clients Who Want to Lose Weight 10% Off Coupons When Signing Up For the Company’s Monthly Newsletter
10. InventHelp® Clients Patent “Foot Rest Saver” – Convenient Tether Accessory Invented to Keep Footrests with a Wheelchair
11. Lambda Solutions Announces Performance Management for Corporate Clients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... There’s no ... possible, even when it comes time to cook the next meal, making July the ... July by practicing best grilling tips and recipes. , Make the next cookout different ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable ... looking to catch a new and refreshing show on Broadway, look no further than ... including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel Award, ...
(Date:7/31/2015)... ... , ... Cosmetic Town has proven itself as the leader ... procedures including, but not limited to, abdominoplasty, blepharoplasty, rhinoplasty and septoplasty. The ... , Staying up to date with the latest cosmetic trends has never ...
(Date:7/31/2015)... ... 2015 , ... “Engage: Don’t Just Age” will be the ... symposiums, hosted by Massachusetts-based Harmony Healthcare International at Foxwoods Resort Casino in ... executives, administrators, directors of nursing, rehabilitation managers and other management and corporate personnel ...
(Date:7/31/2015)... ... July 31, 2015 , ... BioViva USA, Inc. (“BioViva”), a to-clinic gene ... diseases. , BioViva announces it has begun a fundraiser through Maximum Life Foundation ... and find a cure. MaxLife will grant 100% of the money raised to BioViva ...
Breaking Medicine News(10 mins):Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3
... Rapidly improving technology is making LASIK safer, as well ... to A. John Kanellopoulous, MD, who taught an instructional ... Joint Meeting. ,During the course titled “LASIK in ... Technique and Possible Complications and their Management,” Dr. Kanellopoulous, ...
... (EMBL) Mouse Biology Unit in Monterotondo, Italy, and the ... the first time investigate the molecular basis of memory ... current issue of Learning and Memory, identified a molecule ... the signaling pathway through which it affects memory. ...
... found a solution for people suffering from winter depression, ... were published in the American Journal of Psychiatry. ... Dawn Simulator that mimics the atmosphere of dawn, helping ... and the “Negative Air Ionization" delivered at the bedside, ...
... a 39 % increase since 1999 leaving the UK health ... and composting bins are said to be the cause of ... the National Pest Technicians Association (NPTA) said: "It's a grave ... to give rise to some kind of public health risk.” ...
... UNICEF has provided about 1,000 insecticide-treated nets (ITN’s) to ... recent outbreak of malaria in the country, the// Caribbean ... to provide a total of 3,000 ITNs by the ... director of emergency, disaster management and special services. ...
... among states and union territories to enforce screening of all ... disorder// that could lead to disabilities. ,Chandigarh ... children would be done to check any adverse fallout later. ... ,While poor people would be provided the facility ...
Cached Medicine News:Health News:Technology Making LASIK Safer for Those Who Have Had Previous Eye Surgery 2Health News:Researchers Investigate Molecular Basis of Memory 2Health News:Dawn Machine Beats Wintertime Blues 2
(Date:7/31/2015)... , July 31, 2015 Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of its previously announced underwritten public offering of ... public offering price of $11.25 per share. The ... 1,000,000 shares issued upon the exercise in full ...
(Date:7/31/2015)... Calif. , July 31, 2015  Xencor, Inc. ... engineered monoclonal antibodies for the treatment of autoimmune diseases, ... appointment of Yujiro S. Hata to its ... experience in business and corporate development is a tremendous ... Ph.D., president and chief executive officer of Xencor. "Xencor ...
(Date:7/30/2015)... 2015 Edwards Lifesciences Corporation (NYSE: EW ), ... hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the lifesciences ... him on Edwards, board as we pursue our focused innovation ... CEO.  "Bob has provided a valuable perspective to our board, ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... Halozyme Therapeutics,Inc. (Nasdaq: HALO ), a ... extracellular matrix, today announced,that enrollment is complete in ... of superficial bladder cancer. The Company began dosing,patients ... following the successful,completion of the initial Phase I ...
... Pharmacopeia,(Nasdaq: PCOP ), an innovator in ... today announced that Schering-Plough has,initiated a Phase 1 ... a,compound identified from the collaboration between the two ... treatment for respiratory,disease. Pharmacopeia will receive a $1 ...
Cached Medicine Technology:Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer 2Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer 3Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer 4Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 2Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 3Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 4
... System RS 800 can sort different specimen ... sorting are not necessary anymore and all ... a very timesaving and economical way ... a Tube Type Identification via Cap Recognition ...
... detect sequences of the following viruses: ... and 3; influenza virus A and ... and B. Laboratories may use ... *Analyte Specific Reagents. Analytical ...
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... for the detection of two genetic ... mutation on the Factor V (Leiden) ... the Prothrombin gene. Laboratories may use ... *Analyte Specific Reagents. Analytical ...
Medicine Products: